Condensed Consolidated Statements of Shareholders' Equity - USD ($) $ in Thousands	Ordinary Shares	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit	Total
Beginning balance at Dec. 31, 2023	$ 550	$ 883,446	$ (1,304)	$ (511,760)	$ 370,932
Beginning balance (in shares) at Dec. 31, 2023	42,431,766
Increase (decrease) in shareholders' equity (deficit)
Issuance of ADSs upon exercise of share options	$ 2	1,868			1,870
Issuance of ADSs upon exercise of share options (in shares)	133,735
Issuance of ADSs upon settlement of restricted share units	$ 1				1
Issuance of ADSs upon settlement of restricted share units (in shares)	67,096
Share-based compensation expense		9,282			9,282
Foreign currency translation adjustment			526		526
Net Income (Loss)				(26,563)	(26,563)
Ending balance at Mar. 31, 2024	$ 553	894,596	(778)	(538,323)	356,048
Ending balance (in shares) at Mar. 31, 2024	42,632,597
Beginning balance at Dec. 31, 2024	$ 890	1,472,842	119	(680,791)	$ 793,060
Beginning balance (in shares) at Dec. 31, 2024	69,061,418				69,061,418
Increase (decrease) in shareholders' equity (deficit)
Issuance of ADSs upon settlement of restricted share units	$ 2				$ 2
Issuance of ADSs upon settlement of restricted share units (in shares)	140,937
Share-based compensation expense		9,605			9,605
Foreign currency translation adjustment			(1,580)		(1,580)
Net Income (Loss)				(60,754)	(60,754)
Ending balance at Mar. 31, 2025	$ 892	$ 1,482,447	$ (1,461)	$ (741,545)	$ 740,333
Ending balance (in shares) at Mar. 31, 2025	69,202,355				69,202,355